Hans K Hasselbalch

Hans K Hasselbalch

Clinical Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
71 - 80 out of 133Page size: 10
Sort by: 1st author
  1. Published

    Forhøjede blodcelletal og vaskulær sygdom med de myeloproliferative neoplasier som modelsygdomme

    Hasselbalch, Hans Carl, Knudsen, T. A., Sørensen, A. L., Christensen, S. F., Larsen, Morten Kranker, Bak, M., El Fassi, D., Cordua, S., Brabrand, M., Thomsen, G., Stentoft, J., Starklint, J., Ellervik, Christina, Wienecke, Troels, Bruun, Niels Eske, Eickhardt-Dalbøge, C. E., Kjær, L. & Skov, V., 18 Oct 2021, In: Ugeskrift for Laeger. 183, 42, 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    The pathobiology of thrombosis, microvascular disease, and hemorrhage in the myeloproliferative neoplasms

    Hasselbalch, Hans Carl, Elvers, M. & Schafer, A. I., 2021, In: Blood. 137, 16, p. 2152-2160 9 p.

    Research output: Contribution to journal › Review › Research › peer-review

  3. Published

    Molecular profiling as a novel tool to predict response to interferon-α2 in MPNs: The proof of concept in early myelofibrosis

    Hasselbalch, Hans Carl, 2017, In: Cancer. 123, 14, p. 2600-2603

    Research output: Contribution to journal › Editorial › Research

  4. Published

    CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties

    Hasselbalch, Hans Carl, Kristiansen, M. H., Kjær, L., Skov, V., Larsen, Morten Kranker, Ellervik, Christina & Wienecke, Troels, 2024, In: Blood advances. 8, 3, p. 681-682 2 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  5. Published

    Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms

    Hasselbalch, Hans Carl, Junker, P., Skov, V., Kjær, L., Knudsen, T. A., Larsen, Morten Kranker, Holmström, M. O., Andersen, Mads Hald, Jensen, C., Karsdal, M. A. & Willumsen, N., 2023, In: Cancers. 15, 17, 47 p., 4323.

    Research output: Contribution to journal › Review › Research › peer-review

  6. Published

    New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms

    Hasselbalch, Hans Carl & Silver, R. T., 2021, In: HemaSphere. 5, 12, p. 1-7 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer's disease: evidences and perspectives

    Hasselbalch, Hans Carl, Skov, V., Kjær, L., Sørensen, Torben Lykke, Ellervik, Christina & Wienecke, Troels, 2020, In: Journal of Neuroinflammation. 17, 13 p., 248.

    Research output: Contribution to journal › Review › Research › peer-review

  8. Published

    Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives

    Hasselbalch, Hans Carl, Skov, V., Kjær, L., Larsen, Morten Kranker, Knudsen, T. A., Lucijanić, M. & Kusec, R., 2022, In: Cancers. 14, 22, 5495.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms

    Hasselbalch, Hans Carl, 1 Dec 2011, In: Expert Review of Hematology. 4, 6, p. 637-655 19 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Interferon alpha2 in the treatment of hematological malignancies. status and perspectives

    Hasselbalch, Hans Carl, 1 Jan 2011, In: Current Drug Targets. 12, 3, p. 387-391 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...4 5 6 7 8 9 10 11 ...14 Next

ID: 2849472